PI3K inhibitors in haematological malignancies

Matthew J. Matasar; Florian Hiemeyer; Barrett H. Childs; Pier Luigi Zinzani

doi:10.1016/S1470-2045(22)00332-1

PI3K inhibitors in haematological malignancies

Matthew J. Matasar
, Florian Hiemeyer
, Barrett H. Childs
, Pier Luigi Zinzani

Research output: Contribution to journal › Letter › peer-review

Original language	American English
Pages (from-to)	e365
Journal	The Lancet Oncology
Volume	23
Issue number	8
DOIs	https://doi.org/10.1016/S1470-2045(22)00332-1
State	Published - Aug 2022
Externally published	Yes

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(22)00332-1

Cite this

@article{359214cf33d24f10978e6b83bb347017,

title = "PI3K inhibitors in haematological malignancies",

author = "Matasar, \{Matthew J.\} and Florian Hiemeyer and Childs, \{Barrett H.\} and Zinzani, \{Pier Luigi\}",

year = "2022",

month = aug,

doi = "10.1016/S1470-2045(22)00332-1",

language = "American English",

volume = "23",

pages = "e365",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "8",

}

TY - JOUR

T1 - PI3K inhibitors in haematological malignancies

AU - Matasar, Matthew J.

AU - Hiemeyer, Florian

AU - Childs, Barrett H.

AU - Zinzani, Pier Luigi

PY - 2022/8

Y1 - 2022/8

UR - https://www.scopus.com/pages/publications/85134918534

UR - https://www.scopus.com/pages/publications/85134918534#tab=citedBy

U2 - 10.1016/S1470-2045(22)00332-1

DO - 10.1016/S1470-2045(22)00332-1

M3 - Letter

C2 - 35901826

SN - 1470-2045

VL - 23

SP - e365

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -

PI3K inhibitors in haematological malignancies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this